17.62
Bicara Therapeutics Inc Azioni (BCAX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Operating Expenses |
0.48%
59.95
|
60.24 | 41.12 | 40.68 | 32.02 |
| Operating Income/Loss |
0.48%
-59.95
|
-60.24 | -41.12 | -40.68 | -32.02 |
| Nonoperating Income/Loss |
12.07%
4.576
|
4.083 | 3.789 | 4.386 | 4.682 |
| Income/Loss From Continuing Operations Before Tax |
1.40%
-55.38
|
-56.16 | -37.33 | -36.29 | -27.34 |
| Income Tax Expense/Benefit |
17.31%
0.061
|
0.052 | 0.053 | 0.04 | 0.052 |
| Net Income/Loss |
1.38%
-55.44
|
-56.21 | -37.39 | -36.33 | -27.39 |
| Basic Average Shares |
11.87%
67.93
|
60.72 | - | 54.56 | 54.54 |
| Diluted Average Shares |
11.87%
67.93
|
60.72 | - | 54.56 | 54.54 |
| Basic Earnings Per Share |
11.83%
-0.82
|
-0.93 | - | -0.67 | -0.50 |
| Diluted Earnings Per Share |
11.83%
-0.82
|
-0.93 | - | -0.67 | -0.50 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):